Immune Response to Leishmania Major - Richard Titus

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: Research Project (R01)
Project #: 5R01AI029955-05
Application #: 2065337
Study Section: Tropical Medicine and Parasitology Study Section (TMP)

Project Start: 1993-04-01
Project End: 1998-06-30
Budget Start: 1996-07-01
Budget End: 1998-06-30
Support Year: 5
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: Colorado State University-Fort Collins
Department: Pathology
Type: Schools of Veterinary Medicine
DUNS #: 112617480

City: Fort Collins
State: CO
Country: United States
Zip Code: 80523

Related projects


NIH 2001 R01 AI	Immune Response to Leishmania Major Titus, Richard Graeme / Colorado State University-Fort Collins	$309,050
NIH 2000 R01 AI	Immune Response to Leishmania Major Titus, Richard Graeme / Colorado State University-Fort Collins	$299,737
NIH 1999 R01 AI	Immune Response to Leishmania Major Titus, Richard Graeme / Colorado State University-Fort Collins
NIH 1998 R01 AI	Immune Response to Leishmania Major Titus, Richard Graeme / Colorado State University-Fort Collins
NIH 1996 R01 AI	Immune Response to Leishmania Major Titus, Richard Graeme / Colorado State University-Fort Collins
NIH 1995 R01 AI	Immune Response to Leishmania Major Titus, Richard Graeme / Colorado State University-Fort Collins
NIH 1994 R01 AI	Immune Response to Leishmania Major Titus, Richard Graeme / Harvard University
NIH 1994 R01 AI	Immune Response to Leishmania Major Titus, Richard Graeme / Colorado State University-Fort Collins
NIH 1993 R01 AI	Immune Response to Leishmania Major Titus, Richard Graeme / Harvard University

Publications

Al-Wabel, Mohammad A; Tonui, Willy K; Cui, Liwang et al. (2007) Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania. Am J Trop Med Hyg 77:1060-5

DeKrey, G K; Titus, R G (1999) A method for the isolation and analysis of leucocytic cells from Leishmanial ear lesions in mice. J Immunol Methods 228:1-11

Wershil, B K; Theodos, C M; Galli, S J et al. (1994) Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol 152:4563-71

Chakkalath, H R; Titus, R G (1994) Leishmania major-parasitized macrophages augment Th2-type T cell activation. J Immunol 153:4378-87

Kimsey, P B; Theodos, C M; Mitchen, T K et al. (1993) An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB/c mice against infection with virulent L. major. Infect Immun 61:5205-13

Shankar, A; Mitchen, T K; Hall, L R et al. (1993) Reversion to virulence in Leishmania major correlates with expression of surface lipophosphoglycan. Mol Biochem Parasitol 61:207-16

Shankar, A H; Titus, R G (1993) Leishmania major-specific, CD4+, major histocompatibility complex class II-restricted T cells derived in vitro from lymphoid tissues of naive mice. J Exp Med 178:101-11

Comments

Be the first to comment on Richard Titus's grant